HomeInsightsPE

Nath Bio-genes (india) Ltd PE Ratio

Nath Bio-genes (india) Ltd PE Ratio

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

9.3 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Nath Bio-Genes (India) Ltd

NSE: NATHBIOGEN

PE

10.4

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Nath Bio-Genes (India) Ltd is 10.4 as of 12 Dec 11:09 AM .
  • The P/E Ratio of Nath Bio-Genes (India) Ltd changed from 7.7 on March 2023 to 8.3 on March 2024 . This represents a CAGR of 3.82% over 2 years.
  • The Latest Trading Price of Nath Bio-Genes (India) Ltd is ₹ 203.5 as of 12 Dec 11:01 .
  • The PE Ratio of Miscellaneous Industry has changed from 89.1 to 36.1 in 5 years. This represents a CAGR of -16.53%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Miscellaneous industry is 63.2. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Nath Bio-Genes (India) Ltd

No data available

Company Fundamentals for Nath Bio-Genes (India) Ltd

No data available

Image

Nath Bio-Genes (India) Ltd

NSE: NATHBIOGEN

Share Price

₹ 203.5

-0.60 (-0.29%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Nath Bio-Genes (India) Ltd

1M

1Y

3Y

5Y

Monitoring Nath Bio-Genes (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 2024204.1
10 Dec 2024204.25
09 Dec 2024203.25
06 Dec 2024196.05
05 Dec 2024198.6
04 Dec 2024201.2
03 Dec 2024198.05
02 Dec 2024199.2
29 Nov 2024191.7
28 Nov 2024188.45

SWOT Analysis Of Nath Bio-Genes (India) Ltd

Strength

3

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Nath Bio-Genes (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Nath Bio-Genes (India) Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Nath Bio-Genes (India) Ltd10387
GMR Airports Ltd090,216
SJVN Ltd5047,236
Sagility India Ltd8720,069
Godrej Agrovet Ltd3715,015
Rites Ltd3614,589

Key Valuation Metric of Nath Bio-Genes (India) Ltd

No data available

No data available

PE Ratio of Miscellaneous Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Nath Bio-Genes (India) Ltd

No data available

* All values are in crore

Historical Revenue of Nath Bio-Genes (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Nath Bio-Genes (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Nath Bio-Genes (India) Ltd

No data available

* All values are in crore

Historical Dividend Payout of Nath Bio-Genes (India) Ltd

No data available

* All values are in %

About Nath Bio-Genes (India) Ltd

  • Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
  • The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.

Nath Bio-Genes (India) Ltd News Hub

News

Nath Bio-Genes (India) consolidated net profit declines 0.24% in the June 2024 quarter

Net profit of Nath Bio-Genes (India) declined 0.24% to Rs 33.35 crore in the quarter ended...

Read more

2024-08-07 00:00:00

News

Nath Bio-Genes (India) announces board meeting date

Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

2024-10-17 00:00:00

News

Nath Bio-Genes (India) standalone net profit rises 79.50% in the September 2024 quarter

Net profit of Nath Bio-Genes (India) rose 79.50% to Rs 2.89 crore in the quarter ended Sep...

Read more

2024-10-23 00:00:00

News

Nath Bio-Genes (India) consolidated net profit declines 26.49% in the September 2024 quarter

Net profit of Nath Bio-Genes (India) declined 26.49% to Rs 1.11 crore in the quarter ended...

Read more

2024-10-23 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Nath Bio-Genes (India) Ltd

What is the current PE Ratio of Nath Bio-Genes (India) Ltd?

The Current PE Ratio of Nath Bio-Genes (India) Ltd is 10.35 as on 12 Dec 2024.

What is the average PE Ratio of the Miscellaneous industry?

The average industry PE Ratio of Miscellaneous is 63.2 as on 12 Dec 2024.

What was the PE Ratio of Nath Bio-Genes (India) Ltd last year?

The PE Ratio of Nath Bio-Genes (India) Ltd was 7.69 last year, now the PE ratio is 10.35, showing a year-on-year growth of 34.6%.

What does the PE Ratio of Nath Bio-Genes (India) Ltd indicate about its stock?

The PE Ratio of Nath Bio-Genes (India) Ltd is 10.35. This ratio indicates that investors are willing to pay 10.35 times the earnings per share for each share of Nath Bio-Genes (India) Ltd.

What is the PE Ratio Growth of Nath Bio-Genes (India) Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Nath Bio-Genes (India) Ltd grew by 34.6% whereas, the EPS ratio grew by -97.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions